Division of Laboratory Systems (DLS)
What's New
- FDA Issues New Guidance on FDA-Cleared Molecular Influenza and RSV Tests
- NEW Web Page: Guidance for SARS-CoV-2 Point-of-Care Testing
- LIVD Code Selection Guidelines for Laboratories Using Lab-Developed Tests
- FDA Suspends Review of EUA Requests for Lab-Developed SARS-CoV-2 Tests
- FDA Updates the SARS-CoV-2 Reference Panel Comparative Data
DLS Vision
Exemplary laboratory science and practice drive clinical care and public health.
DLS Mission
Improve public health surveillance and practice as well as patient outcomes by advancing clinical laboratory quality and safety, data and biorepository science, and workforce competency.
Key Resources
- Preparing and Supporting Laboratories Responding to COVID-19
- LOINC In Vitro Diagnostic (LIVD) Test Code Mapping for SARS-CoV-2 Tests
- Biosafety Guidelines for Handling and Processing COVID-19 Specimens
- Waived Testing Educational Materials
- Laboratory Communicators’ Network (LCN)
- Competency Guidelines for Laboratory Professionals
- DLS Publications
- Free Educational Materials
- Medical Laboratory Professionals Week (Lab Week)
- Enhancing Public Health Laboratory Capabilities and Increasing Capacity OE20-2001
Page last reviewed: October 23, 2020
Content source: Division of Laboratory Systems (DLS)